Does Histology Predict Survival of Advanced Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy? An Analysis of the Eastern Cooperative Oncology Group Study E1594

Lignende værker

• Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials
  af: Dahlberg, Suzanne E., et al.
  Udgivet: (2013)
• Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599
  af: Brahmer, Julie R., et al.
  Udgivet: (2011)
• Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501
  af: Horn, Leora, et al.
  Udgivet: (2009)
• Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study
  af: Aisner, Seena C., et al.
  Udgivet: (2010)
• Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab
  af: Wakelee, H.A., et al.
  Udgivet: (2012)